Streetbeat News

Price Targets

ORIC

Wedbush analyst David Nierengarten has reiterated an Outperform rating for ORIC Pharmaceuticals, maintaining a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:58 pm

SEAT

Craig-Hallum analyst Ryan Sigdahl maintains a Buy rating on Vivid Seats (NASDAQ:SEAT) but lowers the price target from $10 to $8.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:58 pm

VTR

Wedbush analyst Richard Anderson maintains an Outperform rating on Ventas (NYSE:VTR) and raises the price target from $64 to $71.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:54 pm

COO

Morgan Stanley analyst Patrick Wood maintains an Equal-Weight rating on Cooper Companies (NASDAQ:COO) and raises the price target from $95 to $104.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:53 pm

ANRO

Wedbush analyst Laura Chico has reiterated an Outperform rating for Alto Neuroscience (NYSE:ANRO) and maintained a price target of $29.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:52 pm

HRMY

UBS has initiated coverage on Harmony Biosciences with a Buy rating and set a price target of $56.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:50 pm

BUD

Morgan Stanley analyst Sarah Simon maintains an Overweight rating on Anheuser-Busch InBev (NYSE:BUD) and raises the price target from $68.5 to $73.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:50 pm

BDTX

Wedbush analyst Robert Driscoll has reiterated an Outperform rating for Black Diamond Therapeutic (NASDAQ:BDTX) and maintained a price target of $16.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:50 pm

AAPL

Morgan Stanley analyst Erik Woodring maintains an Overweight rating on Apple with a $273 price target.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:47 pm

CNSP

Maxim Group has upgraded CNS Pharma (NASDAQ:CNSP) from Hold to Buy, setting a price target of $0.5. This upgrade by analyst Jason McCarthy suggests a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:45 pm